Correlation between Interstitial Lung Disease Morphology Scores Based on High-resolution Computed Tomography Chest and Skin Fibrosis Degree Based on Modified Rodnan’s Skin Score on Systemic Sclerosis

Irma Hassan Hikmat, Suci Syamsiah Ramdhini, Hari Soekersi, Sumartini Dewi

Abstract


Background: Systemic sclerosis (SSc) is a systemic autoimmune disease involving a multisystem. Modified Rodnan’s Skin Score (MRSS) is a gold standard for measuring skin fibrosis in SSc. In SSc, lung fibrosis disorders, especially interstitial lung disease (ILD), are the leading cause of mortality and often late in diagnosis. High-Resolution Computed Tomography (HRCT) Chest scan is a gold standard for evaluating ILD morphology, but its availability is limited. The degree of skin fibrosis based on MRSS in SSc can predict the presence of ILD in several studies but has not been widely studied in Indonesia. This study aimed to determine the relationship of the ILD morphology based on thoracic HRCT scan with the degree of skin fibrosis based on MRSS in SSc. Methods: This study is a retrospective analytic observational study with a cross-sectional design. The subjects of this study are SSc patients who had data of MRSS and HRCT chest scan from July 2019 to March 2020. Statistical analysis uses Spearman’s correlation test. Results: There were 42 study subjects, consisting of 41 women (97.6%) and one man (2.4%) with an average age of 39.50 years old (age range of 19 years to 60 years old). Correlation test results based on Spearman’s show a moderate correlation between the morphological score of ILD with MRSS with R = 0.429, which is significant (p = 0.005). Conclusion: There is a significant moderate correlation between the morphological scores of ILD based on HRCT chest and the degree of skin fibrosis based on MRSS in SSc.


Keywords


High-resolution computed tomography chest; interstitial lung disease; modified Rodnan’s skin score; systemic sclerosis

References


Vincent V, Dewi S, Wachjudi R. Correlation Between Serum Procollagen Type 1 N-Terminal Propeptide Level With Modified Rodnan’s Skin Score In Systemic Sclerosis Patients. Indonesian Journal of Rheumatology. 2018;9.

Denton C, Khanna D. Systemic sclerosis. www.thelancet.com. 2017;390.

Budiman A, Dewi S, Prananta M. Clinical Manifestation and Laboratory Finding of Sclerosis Systemic Patient in Dr. Hasan Sadikin General Hospital Bandung - A Descriptive Quantitative Study. Indonesian Journal of Rheumatology. 2018;10(1).

Domsic RT, Rodriguez-Reyna T, Lucas M, Fertig N, Medsger TA, Jr. Skin thickness progression rate: a predictor of mortality and early internal organ involvement in diffuse scleroderma. Ann Rheum Dis. 2011 Jan;70(1):104-9.

Matsuda KM, Yoshizaki A, Kuzumi A, Fukasawa T, Ebata S, Miura S, et al. Skin thickness score as a surrogate marker of organ involvements in systemic sclerosis: a retrospective observational study. Arthritis Res Ther. 2019 May 28;21(1):129.

Deepa AS, Rachel RP, Ramchandran P, Devaraj U, Arnold SA, Shobha V, et al. Pulmonary involvement in systemic sclerosis: A clinical profile. Lung India. 2016 Mar-Apr;33(2):144-7.

Cottrell T, Robert A Wise, Wigley FrM, Boin3 F. The degree of skin involvement identifies distinct lung disease outcomes and survival in systemic sclerosis. Ann Rheum Dis 2014. 2014;73:1060–1066.

Peroš-Golubičić T. Scleroderma and Lung. Interstitial Lung Disease (Clinical Focus). Jaypee Brothers Medical Publishers; 2011

Strollo D, Goldin J. Imaging lung disease in systemic sclerosis. Current rheumatology reports. 2010;12(2):156-61.

Caron M, Hoa S, Hudson M, Schwartzman K, Steele R. Pulmonary function tests as outcomes for systemic sclerosis interstitial lung disease. European Respiratory Review. 2018;27(148):170102.

Veraldi KL, Hsu E, Feghali-Bostwick CA. Pathogenesis of pulmonary fibrosis in systemic sclerosis: lessons from interstitial lung disease. Current rheumatology reports. 2010;12(1):19-25.

Hussein K, Shaaban LH, Mohamed E. Correlation of high-resolution CT patterns with pulmonary function tests in patients with interstitial lung diseases. Egyptian Journal of Chest Diseases and Tuberculosis. 2016;65(3):681-8.

Wu W, Jordan S, Graf N, de Oliveira Pena J, Curran J, Allanore Y, et al. Progressive skin fibrosis is associated with a decline in lung function and worse survival in patients with diffuse cutaneous systemic sclerosis in the European Scleroderma Trials and Research (EUSTAR) cohort. Ann Rheum Dis. 2019 May;78(5):648-56.

Wangkaew S, Euathrongchit J, Wattanawittawas P, Kasitanon N. Correlation of delta high-resolution computed tomography (HRCT) score with delta clinical variables in early systemic sclerosis (SSc) patients. Quant Imaging Med Surg. 2016 Aug;6(4):381-90.

Yani H, Dewi S, Rahmadi AR. Correlation between Serum Krebs von den Lungen-6 Levels with Forced Vital Capacity and Modified Rodnan Skin Score of Patients with Restrictive Lung Disease in Diffuse-Type Systemic Sclerosis. Indonesioan Journal of Rheumatology. 2019;11(2):145-17.


Full Text: PDF

Refbacks

  • There are currently no refbacks.


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.